PRESS-NEWS.org - Press Release Distribution
PRESS RELEASES DISTRIBUTION

Sacituzumab govitecan plus platinum-based chemotherapy in breast, bladder, and lung carcinomas

Sacituzumab govitecan plus platinum-based chemotherapy in breast, bladder, and lung carcinomas
2024-03-04
(Press-News.org)

“[...] these results support the rationale and potential for favorable clinical outcomes of combining SG therapy with platinum-based chemotherapeutics in solid tumors.”

BUFFALO, NY- March 4, 2024 – A new research paper was published in Oncotarget's Volume 15 on February 22, 2024, entitled, “Sacituzumab govitecan plus platinum-based chemotherapy mediates significant antitumor effects in triple-negative breast, urinary bladder, and small-cell lung carcinomas.”

Sacituzumab govitecan (SG) is an antibody-drug conjugate composed of an anti-Trop-2-directed antibody conjugated with the topoisomerase I inhibitory drug, SN-38, via a proprietary hydrolysable linker. SG has received United States Food and Drug Administration (FDA) approval to treat metastatic triple-negative breast cancer (TNBC), unresectable locally advanced or metastatic hormone receptor (HR)-positive, human epidermal growth factor receptor 2 (HER2)-negative breast cancer, and accelerated approval for metastatic urothelial cancer (mUC).

In this new study, researchers Thomas M. Cardillo, Maria B. Zalath, Roberto Arrojo, Robert M. Sharkey, Serengulam V. Govindan, Chien-Hsing Chang, and David M. Goldenberg from Gilead Sciences and the Center for Molecular Medicine and Immunology investigated the utility of combining SG with platinum-based chemotherapeutics in TNBC, urinary bladder carcinoma (UBC), and small-cell lung carcinoma (SCLC). 

“Given recent FDA approval of SG in mTNBC and accelerated approval in mUC [metastatic urothelial cancer], as well as its demonstrated clinical activity in SCLC [11], we investigated the possibility of expanding use of SG through combinations with currently utilized chemotherapeutics for these disease indications.”

SG plus carboplatin or cisplatin produced additive growth-inhibitory effects in vitro that trended towards synergy. Immunoblot analysis of cell lysates suggests perturbation of the cell-cycle and a shift towards pro-apoptotic signaling evidenced by an increased Bax to Bcl-2 ratio and down-regulation of two anti-apoptotic proteins, Mcl-1 and survivin. Significant antitumor effects were observed with SG plus carboplatin in mice bearing TNBC or SCLC tumors compared to all controls (P < 0.0062 and P < 0.0017, respectively) and with SG plus cisplatin in UBC and SCLC tumor-bearing animals (P < 0.0362 and P < 0.0001, respectively). These combinations were well tolerated by the animals. 

“Combining SG with platinum-based chemotherapeutics demonstrates the benefit in these indications and warrants further clinical investigation.”

 

Read the full paper: DOI: https://doi.org/10.18632/oncotarget.28559 

Correspondence to: Thomas M. Cardillo

Email: Thomas.Cardillo1@Gilead.com 

Keywords: sacituzumab govitecan, Trop-2, SN-38, carboplatin, cisplatin

Click here to sign up for free Altmetric alerts about this article.
 

About Oncotarget: Oncotarget (a primarily oncology-focused, peer-reviewed, open access journal) aims to maximize research impact through insightful peer-review; eliminate borders between specialties by linking different fields of oncology, cancer research and biomedical sciences; and foster application of basic and clinical science.

To learn more about Oncotarget, visit Oncotarget.com and connect with us on social media:

X, formerly Twitter Facebook YouTube Instagram LinkedIn Pinterest Reddit Spotify, and available wherever you listen to podcasts

 

Click here to subscribe to Oncotarget publication updates.

For media inquiries, please contact media@impactjournals.com.

 

Oncotarget Journal Office

6666 East Quaker Street., Suite 1A

Orchard Park, NY 14127

Phone: 1-800-922-0957 (option 2)

###

END


[Attachments] See images for this press release:
Sacituzumab govitecan plus platinum-based chemotherapy in breast, bladder, and lung carcinomas Sacituzumab govitecan plus platinum-based chemotherapy in breast, bladder, and lung carcinomas 2 Sacituzumab govitecan plus platinum-based chemotherapy in breast, bladder, and lung carcinomas 3

ELSE PRESS RELEASES FROM THIS DATE:

Global study unveils "problematic" use of porn

2024-03-04
A major international study led by a Canadian psychologist sheds light on a hidden phenomenon: how problematic use of pornography is affecting people in different parts of the world, across various genders and sexual orientations.   Published in the journal Addiction, the  research stands out because, among the 82,000 people in 42 countries studied, it looks at groups that were often overlooked in the past, including women and individuals who don't fit traditional gender categories.   In their findings, largely based on ...

Newly discovered protein prevents DNA triplication

Newly discovered protein prevents DNA triplication
2024-03-04
This is a natural 'anti-failure' mechanism in the DNA copying process, hitherto unknown. The DNA molecule is copied each time a cell divides. If, instead of being copied once, the DNA is copied several times, i.e. tripled or even quadrupled, the likelihood of cancer increases.. The new discovered anti-failure system relies on a protein called RAD51 to prevent DNA that has already been copied from being copied again. Every time a cell divides, its DNA is duplicated so that the two daughter cells have the same genetic material as their parent. This means that millions of times a day ...

Less ice in the arctic ocean has complex effects on marine ecosystems and ocean productivity

Less ice in the arctic ocean has complex effects on marine ecosystems and ocean productivity
2024-03-04
Over the past 25 years, the amount of summer Arctic sea ice has diminished by more than 1 million square kilometers. As a result, vast areas of the Arctic Ocean are now, on average, ice free in summer. Scientists are closely monitoring how this impacts sunlight availability and marine ecosystems in the far north. “Many questions arise when such large areas become ice-free and can receive sunlight. A prevailing paradigm suggests that the Arctic Ocean is rapidly becoming more productive as sunlight becomes ...

Antarctica’s coasts are becoming less icy

Antarctica’s coasts are becoming less icy
2024-03-04
EMBARGOED UNTIL MARCH 4, 2024 AT 3:00PM U.S EASTERN TIME An increase in pockets of open water in Antarctica’s sea ice (polynyas) may mean coastal plants and animals could one day establish on the continent, University of Otago-led research suggests. The research, published in the prestigious international journal Proceedings of the National Academy of Science, aimed at understanding where open water might allow coastal species to settle in the future. Led by Research Fellow Dr Grant Duffy from Otago’s Department ...

New research shows migrating animals learn by experience

New research shows migrating animals learn by experience
2024-03-04
THIS RELEASE IS EMBARGOED UNTIL MARCH 4, 2024, at 3:00 PM U.S. EASTERN TIME. Research led by scientists from University of Wyoming and Max Planck Institute of Animal Behavior shows that migrating animals refine their behavior as they get older, suggesting that experiential learning is an important part of successful migration. While genetics and social behavior are important factors shaping animal migrations, information gained through individual experience also appears to help shape migratory movements, says a research team led by Ellen Aikens. Aikens, ...

Modeling the origins of life: New evidence for an “RNA World”

Modeling the origins of life: New evidence for an “RNA World”
2024-03-04
LA JOLLA (March 4, 2024)—Charles Darwin described evolution as "descent with modification." Genetic information in the form of DNA sequences is copied and passed down from one generation to the next. But this process must also be somewhat flexible, allowing slight variations of genes to arise over time and introduce new traits into the population. But how did all of this begin? In the origins of life, long before cells and proteins and DNA, could a similar sort of evolution have taken place on a simpler scale? ...

Scientists put forth a smarter way to protect a smarter grid

2024-03-04
RICHLAND, Wash.—There’s a down side to “smart” devices: They can be hacked.   That makes the electric grid, increasingly chock full of devices that interact with one another and make critical decisions, vulnerable to bad actors who might try to turn off the power, damage the system or worse.   But smart devices are a big part of our future as the world moves more toward renewable energy and the many new devices to manage it. Already, such tools play a big role in keeping the power humming. The portion of the grid owned by ...

An evolutionary mystery 125 million years in the making

An evolutionary mystery 125 million years in the making
2024-03-04
Plant genomics has come a long way since Cold Spring Harbor Laboratory (CSHL) helped sequence the first plant genome. But engineering the perfect crop is still, in many ways, a game of chance. Making the same DNA mutation in two different plants doesn’t always give us the crop traits we want. The question is why not? CSHL plant biologists just dug up a reason. CSHL Professor and HHMI Investigator Zachary Lippman and his team discovered that tomato and Arabidopsis thaliana plants can use very different regulatory systems to control the same exact ...

Data science approach to identifying thermal conductivity-related structural factors in amorphous materials

Data science approach to identifying thermal conductivity-related structural factors in amorphous materials
2024-03-04
1. Using data science techniques, a NIMS–Tohoku University research team has discovered that different thermal conductivities exhibited by an amorphous material with the same composition are attributable to the sizes of atomic rings in its atomic structure. This is one of the first studies demonstrating that the structural features of amorphous materials can be correlated with their physical properties. 2. It is already feasible to synthesize amorphous materials with the same compositions but different thermal conductivities. However, the structural factors responsible for differences in thermal conductivity had yet to be identified due to a lack of appropriate analytical ...

Deciphering the male breast cancer genome

2024-03-04
Male breast cancer has distinct alterations in the tumor genome that may suggest potential treatment targets, according to a study by Weill Cornell Medicine investigators. They have conducted the first whole genome sequencing analysis of male breast cancer, which looked at the complete DNA landscape of tumor samples from 10 patients. This is an important step in viewing breast cancer in men, which represents less than 1 percent of all breast cancer cases each year, as a unique disease. Though most research has focused on women with breast cancer, the incidence in men has increased at a much faster rate than in women over the last 40 years. Also, ...

LAST 30 PRESS RELEASES:

ASH 2025: Antibody therapy eradicates traces of multiple myeloma in preliminary trial

ASH 2025: AI uncovers how DNA architecture failures trigger blood cancer

ASH 2025: New study shows that patients can safely receive stem cell transplants from mismatched, unrelated donors

Protective regimen allows successful stem cell transplant even without close genetic match between donor and recipient

Continuous and fixed-duration treatments result in similar outcomes for CLL

Measurable residual disease shows strong potential as an early indicator of survival in patients with acute myeloid leukemia

Chemotherapy and radiation are comparable as pre-transplant conditioning for patients with b-acute lymphoblastic leukemia who have no measurable residual disease

Roughly one-third of families with children being treated for leukemia struggle to pay living expenses

Quality improvement project results in increased screening and treatment for iron deficiency in pregnancy

IV iron improves survival, increases hemoglobin in hospitalized patients with iron-deficiency anemia and an acute infection

Black patients with acute myeloid leukemia are younger at diagnosis and experience poorer survival outcomes than White patients

Emergency departments fall short on delivering timely treatment for sickle cell pain

Study shows no clear evidence of harm from hydroxyurea use during pregnancy

Long-term outlook is positive for most after hematopoietic cell transplant for sickle cell disease

Study offers real-world data on commercial implementation of gene therapies for sickle cell disease and beta thalassemia

Early results suggest exa-cel gene therapy works well in children

NTIDE: Disability employment holds steady after data hiatus

Social lives of viruses affect antiviral resistance

Dose of psilocybin, dash of rabies point to treatment for depression

Helping health care providers navigate social, political, and legal barriers to patient care

Barrow Neurological Institute, University of Calgary study urges “major change” to migraine treatment in Emergency Departments

Using smartphones to improve disaster search and rescue

Robust new photocatalyst paves the way for cleaner hydrogen peroxide production and greener chemical manufacturing

Ultrafast material captures toxic PFAS at record speed and capacity

Plant phenolic acids supercharge old antibiotics against multidrug resistant E. coli

UNC-Chapel Hill study shows AI can dramatically speed up digitizing natural history collections

OYE Therapeutics closes $5M convertible note round, advancing toward clinical development

Membrane ‘neighborhood’ helps transporter protein regulate cell signaling

Naval aviator turned NPS doctoral student earns national recognition for applied quantum research

Astronomers watch stars explode in real time through new images

[Press-News.org] Sacituzumab govitecan plus platinum-based chemotherapy in breast, bladder, and lung carcinomas